Our study showed that PIK3CA mutant tumors with low AKT phospho-Ser473 and high ERα phospho-Ser167 (Type G) was the most frequent type in postmenopausal women, and almost 30% of postmenopausal ER-positive, HER2-negative breast cancer were classified as this type. This evidence concerns the gene ERBB2 and breast cancer.